Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years)

. 2003 Jul ; 131 (3) : 209-11.

Jazyk angličtina Země Švýcarsko Médium print

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid12876412

BACKGROUND: The development of allergies is a complex in which both composition and influence of the intestinal flora play an important role. We observed in earlier studies that the presence of an orally administered probiotic Escherichia coli strain in the intestine stimulated both a serum and local antibody response, decreased the presence of pathogens, the number of infections and the need for antibiotics. METHODS: The preventive effect of oral colonization after birth with a probiotic E. COLI strain was assessed by evaluating the results of a questionnaire both 20 years (150 full-term infants) and 10 years (77 preterm infants) after colonization. RESULTS: Differences in occurrence of allergies in colonized and control subjects were statistically significant both after 10 and 20 years (p < 0.01). Specific serum IgE antibodies confirmed the presence of allergies in 100% of 10-year-old and 91% of 20-year-old patients with clinical symptoms of allergy. Ten years after colonization, the occurrence of repeated infections was significantly lower in colonized subjects than it was in controls (p < 0.01); 20 years later, no differences were found in these groups. CONCLUSIONS: Intentional colonization of the intestine with E. coli after birth (offering the advantage of the first colonizer) was found to decrease the incidence of allergies and repeated infections in later life.

Citace poskytuje Crossref.org

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

Bacterial extracellular vesicles as intranasal postbiotics: Detailed characterization and interaction with airway cells

. 2024 Oct ; 13 (10) : e70004.

Extracellular vesicles of the probiotic bacteria E. coli O83 activate innate immunity and prevent allergy in mice

. 2023 Oct 20 ; 21 (1) : 297. [epub] 20231020

The Impact of Escherichia coli Probiotic Strain O83:K24:H31 on the Maturation of Dendritic Cells and Immunoregulatory Functions In Vitro and In Vivo

. 2022 May 12 ; 11 (10) : . [epub] 20220512

Effect of early postnatal supplementation of newborns with probiotic strain E. coli O83:K24:H31 on allergy incidence, dendritic cells, and microbiota

. 2022 ; 13 () : 1038328. [epub] 20230109

Severity of Experimental Autoimmune Uveitis Is Reduced by Pretreatment with Live Probiotic Escherichia coli Nissle 1917

. 2020 Dec 25 ; 10 (1) : . [epub] 20201225

Colonization of germ-free mice with a mixture of three lactobacillus strains enhances the integrity of gut mucosa and ameliorates allergic sensitization

. 2016 Mar ; 13 (2) : 251-62. [epub] 20150323

The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases

. 2011 Mar ; 8 (2) : 110-20. [epub] 20110131

Probiotic Lactobacillus strains: in vitro and in vivo studies

. 2009 Nov ; 54 (6) : 533-7. [epub] 20100207

Treatment of adjuvant-induced arthritis with the combination of methotrexate and probiotic bacteria Escherichia coli O83 (Colinfant)

. 2009 ; 54 (4) : 359-63. [epub] 20091014

Detection of galectin-3 in patients with inflammatory bowel diseases: new serum marker of active forms of IBD?

. 2009 Aug ; 58 (8) : 503-12. [epub] 20090307

Effect of oral application of a probiotic E. coli strain on the intestinal microflora of children of allergic mothers during the first year of life

. 2007 ; 52 (2) : 189-93.

Probiotics manipulate host cytokine response and induce antimicrobial peptides

. 2006 ; 51 (5) : 507-10.

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace